Cosmetic cross-reference Noindex: medium evidence

115-18-4

CAS 115-18-4

115-18-4 (CAS 115-18-4) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

115-18-4

CAS Number

115-18-4

UNII

SH64HE46L9

InChIKey

HNVRRHSXBLFLIG-UHFFFAOYSA-N

ChEMBL ID

CHEMBL4245903

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 115-18-4 used for in pharmaceutical contexts?

115-18-4 (CAS 115-18-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 115-18-4?

No adverse-event association or SIDER side-effect rows are rendered for 115-18-4 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 115-18-4 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for 2-Methyl-3-Buten-2-Ol with EU status "permitted".

What clinical phase is 115-18-4 in?

No phase 1-4 clinical development badge is rendered for 115-18-4 because the matched compound identifier rows do not contain a max-phase value.